{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:40:54Z","timestamp":1763440854305,"version":"3.45.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,17]]},"DOI":"10.7759\/cureus.97108","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:37:47Z","timestamp":1763440667000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Case of Pemphigus Erythematosus in a Previously Healthy Young Woman: Diagnostic Delay and Response to Rituximab"],"prefix":"10.7759","author":[{"given":"Nadia","family":"Kirmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Shegog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00033.x","article-title":"Immunopathology and molecular diagnosis of autoimmune bullous diseases","volume":"11","author":"Mihai S","year":"2007","unstructured":"Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med. 2007, 11:462-81. 10.1111\/j.1582-4934.2007.00033.x","journal-title":"J Cell Mol Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2005.00367.x","article-title":"Mechanisms of blister induction by autoantibodies","volume":"14","author":"Sitaru C","year":"2005","unstructured":"Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol. 2005, 14:861-75. 10.1111\/j.1600-0625.2005.00367.x","journal-title":"Exp Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer N","year":"2010","unstructured":"Meyer N, Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev. 2010, 9:379-82. 10.1016\/j.autrev.2009.10.009","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-019-08774-5","article-title":"The immunopathology of complement proteins and innate immunity in autoimmune disease","volume":"58","author":"Defendi F","year":"2020","unstructured":"Defendi F, Thielens NM, Clavarino G, Cesbron JY, Dumestre-P\u00e9rard C. The immunopathology of complement proteins and innate immunity in autoimmune disease. Clin Rev Allergy Immunol. 2020, 58:229-51. 10.1007\/s12016-019-08774-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich R","year":"2014","unstructured":"Kershenovich R, Hodak E, Mimouni D. Diagnosis and classification of pemphigus and bullous pemphigoid. Autoimmun Rev. 2014, 13:477-81. 10.1016\/j.autrev.2014.01.011","journal-title":"Autoimmun Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin K","year":"2018","unstructured":"Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018, 66:255-70. 10.1007\/s12026-018-8986-7","journal-title":"Immunol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02533.x","article-title":"Pemphigus in the Mediterranean region of Turkey: a study of 148 cases","volume":"45","author":"Uzun S","year":"2006","unstructured":"Uzun S, Durdu M, Akman A, Gunasti S, Uslular C, Memisoglu HR, Alpsoy E. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. Int J Dermatol. 2006, 45:425-8. 10.1111\/j.1365-4632.2004.02533.x","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16889","article-title":"A case of apple-dependent, exercise-induced anaphylaxis with sensitization to gibberellin-regulated proteins","volume":"50","author":"Hagihara E","year":"2023","unstructured":"Hagihara E, Ito H, Okamoto T, Inomata N. A case of apple-dependent, exercise-induced anaphylaxis with sensitization to gibberellin-regulated proteins. J Dermatol. 2023, 50:386-7. 10.1111\/1346-8138.16889","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020409","article-title":"Senear-Usher syndrome or coexistence of SLE with pemphigus vulgaris - a case report with literature review","volume":"14","author":"Kutwin M","year":"2025","unstructured":"Kutwin M, K\u0105dziela M, Stein T, Kraska-Gacka M, Wo\u017aniacka A, \u017bebrowska A. Senear-Usher syndrome or coexistence of SLE with pemphigus vulgaris - a case report with literature review. J Clin Med. 2025, 14:10.3390\/jcm14020409","journal-title":"J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona D","year":"2018","unstructured":"Didona D, Di Zenzo G. Humoral epitope spreading in autoimmune bullous diseases. Front Immunol. 2018, 9:10.3389\/fimmu.2018.00779","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14176","article-title":"Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders","volume":"49","author":"Lehman JS","year":"2022","unstructured":"Lehman JS, Johnson EF, Camilleri MJ, et al.. Impact of adding an IgG4 conjugate to routine direct immunofluorescence testing for subepithelial and intraepithelial autoimmune blistering disorders. J Cutan Pathol. 2022, 49:358-62. 10.1111\/cup.14176","journal-title":"J Cutan Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01990","article-title":"Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders","volume":"10","author":"Kaegi C","year":"2019","unstructured":"Kaegi C, Wuest B, Schreiner J, et al.. Systematic review of safety and efficacy of rituximab in treating immune-mediated disorders. Front Immunol. 2019, 10:10.3389\/fimmu.2019.01990","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"34","author":"Joly P","year":"2020","unstructured":"Joly P, Horvath B, Patsatsi \u0391, et al.. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol. 2020, 34:1900-13. 10.1111\/jdv.16752","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408857-atypical-case-of-pemphigus-erythematosus-in-a-previously-healthy-young-woman-diagnostic-delay-and-response-to-rituximab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T04:37:56Z","timestamp":1763440676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408857-atypical-case-of-pemphigus-erythematosus-in-a-previously-healthy-young-woman-diagnostic-delay-and-response-to-rituximab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.97108","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,17]]}}}